News

UCB announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BRIVIACT (brivaracetam) CV tablets, oral solution, and injection to treat…
Read More...

Roche announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane,…
Read More...

Novartis announced that the European Commission (EC) has granted orphan drug designation to sabatolimab (MBG453) for the treatment of myelodysplastic syndromes (MDS), based on clinical…
Read More...

Novartis  announced results from two pooled post hoc analyses of Phase III ORION-9, -10 and -11 trials that showed twice-yearly Leqvio (inclisiran) provided effective and sustained…
Read More...

BioMarin Pharmaceutical Inc. announced that the European Commission (EC) has granted marketing authorization for VOXZOGO (vosoritide), a once daily injection to treat achondroplasia in…
Read More...

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Japan for the treatment of chronic kidney disease (CKD) in adults with…
Read More...

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,…
Read More...

Thermo Scientific EliA SmDP-S test has been cleared by the U.S. Food & Drug Administration (FDA) for aiding the diagnosis of Systemic Lupus Erythematosus (SLE), the most common type…
Read More...

Ironwood Pharmaceuticals, Inc. a GI-focused healthcare company, announced that the U.S. Food and Drug Administration (FDA) approved a revised label for LINZESS (linaclotide) based on…
Read More...

Pardes Biosciences, Inc., a clinical-stage biopharmaceutical company today announced the initiation of a Phase 1 clinical trial, evaluating the company’s lead candidate, PBI-0451 which…
Read More...

Eagle Pharmaceuticals, Inc. announced that it has entered into a worldwide licensing agreement with Combioxin SA (“Combioxin”), a clinical-stage biotechnology company based in…
Read More...

Eli Lilly and Company and Lycia Therapeutics, Inc. announced a multi-year research collaboration and licensing agreement focused on the discovery, development and commercialization of…
Read More...

Pfizer Inc. and BioNTech SE announced the initiation of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the approval of a booster…
Read More...

Provectus Algae (Provectus), an Australian biotechnology platform company specialising in the biomanufacturing of high-value compounds for a wide array of industries using microalgae,…
Read More...

FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, announces today it has…
Read More...

Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target strategic collaboration and…
Read More...

FLEXcon Company, Inc., an innovator in adhesive coating and laminating, today announced the relaunch of its FLEXcon PHARMcal line of track and trace solutions featuring engineered films…
Read More...

AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib), an oral, selective and reversible JAK inhibitor, for the treatment of moderate to severe atopic dermatitis…
Read More...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical need and large public health burden, announced that its…
Read More...

InDex Pharmaceuticals Holding AB (publ) announced that the U.S. Food and Drug Administration (FDA) has given clearance to start the phase III clinical study CONCLUDE in the United…
Read More...